Effects of Prenatal Spironolactone on Mouse Brain Development
Author Information
Author(s): Jones Stephanie M., Sleiman Sarah Jo, McCann Katharine E., Jarmusch Alan K., Alexander Georgia M., Dudek Serena M.
Primary Institution: National Institute of Environmental Health Sciences
Hypothesis
Disturbing mineralocorticoid receptor function during early development may impair the establishment of CA2 connectivity and its role in behavior.
Conclusion
Prenatal exposure to spironolactone disrupts hippocampal CA2 connectivity and alters behavior in mice.
Supporting Evidence
- Spironolactone treatment caused a significant reduction of CA2 axon fluorescence intensity in the CA1 stratum oriens.
- Animals exposed to spironolactone showed increased reactivity to novel objects.
- vGluT2 staining was significantly decreased in both CA2 and dentate gyrus in spironolactone-treated animals.
Takeaway
Giving pregnant mice a medicine called spironolactone changes how their babies' brains connect and how they act when they grow up.
Methodology
Mice were treated with spironolactone during pregnancy, and their offspring were assessed for brain connectivity and behavior.
Potential Biases
Potential bias in interpreting behavioral results due to the lack of control for environmental factors.
Limitations
The study primarily focused on male and female mice without distinguishing potential sex differences in response to treatment.
Participant Demographics
C57BL/6J mice and Amigo-2 GFP mice were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website